Alterations of N-3 polyunsaturated fatty acid-activated K2P channels in hypoxia-induced pulmonary hypertension

Basic and Clinical Pharmacology and Toxicology

Volumn 113, Issue 4, 2013, Pages 250-258

  Nielsen, Gorm ^a   Wandall Frostholm, Christine ^b   Sadda, Veeranjaneyulu ^a   Oliván Viguera, Aida ^a,c   Lloyd, Eric E ^d   Bryan, Robert M ^d   Simonsen, Ulf ^b   Köhler, Ralf ^a,c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6,10 DIAZA 3(1,3)8,(1,4) DIBENZENA 1,5(1,4) DIQUINOLINACYCLODECAPHANE; ACETYLCHOLINE; CALCIUM ACTIVATED POTASSIUM CHANNEL; DOCOSAHEXAENOIC ACID; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OMEGA 3 FATTY ACID; PIMOZIDE; POTASSIUM CHANNEL; PROSTACYCLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HYPERPOLARIZATION; HYPOXIA; HYPOXIA INDUCED PULMONARY HYPERTENSION; IMMUNOHISTOCHEMISTRY; LUNG ARTERY; LUNG BLOOD VESSEL; MALE; MOUSE; MYOGRAPHY; NONHUMAN; PATCH CLAMP; PATHOPHYSIOLOGY; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASODILATATION;

MURINAE; MUS;

ANIMALS; ANOXIA; DOCOSAHEXAENOIC ACIDS; ELECTROPHYSIOLOGY; EPOPROSTENOL; HYPERTENSION, PULMONARY; LUNG; MALE; MICE; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; PULMONARY ARTERY; RNA, MESSENGER; UP-REGULATION; VASODILATION;

EID: 84883823394     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12092     Document Type: Article

References (32)

1. Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH. Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol 2004;142:192-202.
2. Lembrechts R, Pintelon I, Schnorbusch K, Timmermans JP, Adriaensen D, Brouns I. Expression of mechanogated two-pore domain potassium channels in mouse lungs: special reference to mechanosensory airway receptors. Histochem Cell Biol 2011;136:371-85.
3. Garry A, Fromy B, Blondeau N, Henrion D, Brau F, Gounon P et al. Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link. EMBO Rep 2007;8:354-9.
4. Blondeau N, Petrault O, Manta S, Giordanengo V, Gounon P, Bordet R et al. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res 2007;101:176-84.
5. Namiranian K, Lloyd EE, Crossland RF, Marrelli SP, Taffet GE, Reddy AK et al. Cerebrovascular responses in mice deficient in the potassium channel, TREK-1. Am J Physiol Regul Integr Comp Physiol 2010;299:R461-9.
6. Feletou M, Kohler R, Vanhoutte PM. Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep 2010;12:267-75.
7. Kohler R, Kaistha BP, Wulff H. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease. Expert Opin Ther Targets 2010;14:143-55.
8. Edwards G, Feletou M, Weston AH. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch 2010;459:863-79.
9. Brayden JE, Quayle JM, Standen NB, Nelson MT. Role of potassium channels in the vascular response to endogenous and pharmacological vasodilators. Blood Vessels 1991;28:147-53.
10. Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res 2003;93:957-64.
11. Manoury B, Lamalle C, Oliveira R, Reid J, Gurney AM. Contractile and electrophysiological properties of pulmonary artery smooth muscle are not altered in TASK-1 knockout mice. J Physiol 2011;589:3231-46.
12. Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 2005;97:185-91.
13. Wilkins MR. Pulmonary hypertension: the science behind the disease spectrum. Eur Respir Rev 2012;21:19-26.
14. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest 2012;142:448-56.
15. Hoyer J, Kohler R, Distler A. Mechanosensitive cation channels in aortic endothelium of normotensive and hypertensive rats. Hypertension 1997;30:112-9.
16. Lloyd EE, Crossland RF, Phillips SC, Marrelli SP, Reddy AK, Taffet GE et al. Disruption of K(2P)6.1 produces vascular dysfunction and hypertension in mice. Hypertension 2011;58:672-8.
17. Baandrup JD, Markvardsen LH, Peters CD, Schou UK, Jensen JL, Magnusson NE et al. Pressure load: the main factor for altered gene expression in right ventricular hypertrophy in chronic hypoxic rats. PLoS ONE 2011;6:e15859.
18. Thummler S, Duprat F, Lazdunski M. Antipsychotics inhibit TREK but not TRAAK channels. Biochem Biophys Res Commun 2007;354:284-9.
19. Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL, Mathie A. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol 2005;144:821-9.
20. Kirber MT, Ordway RW, Clapp LH, Walsh JV Jr, Singer JJ. Both membrane stretch and fatty acids directly activate large conductance Ca(2+)-activated K+ channels in vascular smooth muscle cells. FEBS Lett 1992;297:24-8.
21. Wang RX, Chai Q, Lu T, Lee HC. Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity. Cardiovasc Res 2011;90:344-52.
22. Fink M, Duprat F, Lesage F, Reyes R, Romey G, Heurteaux C et al. Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. EMBO J 1996;15:6854-62.
23. Patel AJ, Maingret F, Magnone V, Fosset M, Lazdunski M, Honore E. TWIK-2, an inactivating 2P domain K+ channel. J Biol Chem 2000;275:28722-30.
24. Kroigaard C, Dalsgaard T, Nielsen G, Laursen BE, Pilegaard H, Kohler R et al. Activation of endothelial and epithelial KCa2.3 calcium-activated potassium channels by NS309 relaxes human small pulmonary arteries and bronchioles. Br J Pharmacol 2012;167:37-47.
25. Zhao KQ, Xiong G, Wilber M, Cohen NA, Kreindler JL. A role for two-pore K(+) channels in modulating Na(+) absorption and Cl(-) secretion in normal human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2012;302:L4-12.
26. Chavez RA, Gray AT, Zhao BB, Kindler CH, Mazurek MJ, Mehta Y et al. TWIK-2, a new weak inward rectifying member of the tandem pore domain potassium channel family. J Biol Chem 1999;274:7887-92.
27. Pountney DJ, Gulkarov I, de Vega-Saenz ME, Holmes D, Saganich M, Rudy B et al. Identification and cloning of TWIK-originated similarity sequence (TOSS): a novel human 2-pore K+ channel principal subunit. FEBS Lett 1999;450:191-6.
28. Salinas M, Reyes R, Lesage F, Fosset M, Heurteaux C, Romey G et al. Cloning of a new mouse two-P domain channel subunit and a human homologue with a unique pore structure. J Biol Chem 1999;274:11751-60.
29. Lloyd EE, Marrelli SP, Namiranian K, Bryan RM Jr. Characterization of TWIK-2, a two-pore domain K+ channel, cloned from the rat middle cerebral artery. Exp Biol Med (Maywood) 2009;234:1493-502.
30. Houeijeh A, Aubry E, Coridon H, Montaigne K, Sfeir R, Deruelle P et al. Effects of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation. Crit Care Med 2011;39:1431-8.
31. Morin C, Sirois M, Echave V, Rizcallah E, Rousseau E. Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung. Am J Physiol Lung Cell Mol Physiol 2009;296:L130-9.
32. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985;227:1477-9.